Pfizer AG - Paxlovid, Filmtabletten | | 68793 | | 01 | | Paxlovid | | Filmtabletten | | J05AE30 | | Nirmatrelvir and Ritonavir | | 15.06.2022 | | |
| Composition | A): nirmatrelvirum 150 mg, cellulosum microcristallinum, lactosum monohydricum 185 mg, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), pro compresso obducto corresp. natrium 0.99 mg.
B): ritonavirum 100 mg, copovidonum, silica colloidalis anhydrica, sorbitani lauras, calcii hydrogenophosphas, natrii stearylis fumaras, Überzug: hypromellosum, E 171, macrogolum 400, macrogolum 3350, hydroxypropylcellulosum, talcum, silica colloidalis anhydrica, polysorbatum 80, pro compresso obducto, natrium 0.388 mg. | Packungsbestandteile | | B | | | Comprimés filmés | | | Principe actif | Concentr. |
---|
Ritonavir | 100 mg |
| BAG: Principe actif | Concentr. |
---|
Nirmatrelvirum | 150 mg | Ritonavir | 100 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
Calcium Hydrogenophosphate | | | Copovidonum | | | E 171 | | color. | Hydroxypropylcellulosum | | | Hypromellosum | | Überzug | Macrogol | 3350 | | Natrii Stearylis Fumaras | | | Sodium | 0.388 mg | | Polysorbatum 80 | | | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Sorbitani Lauras | | | Talcum | | |
| |
| A | | | Comprimés filmés | | | Principe actif | Concentr. |
---|
Nirmatrelvirum | 150 mg |
| BAG: Principe actif | Concentr. |
---|
Nirmatrelvirum | 150 mg | Ritonavir | 100 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Rubrum) | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | Hypromellosum | | Überzug | Lactose Monohydrate | 185 mg | | Macrogol | 400 | | Natrii Stearylis Fumaras | | | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
001 | 30 | 958.62 | 1058.95 | A | LS | Oui |
|
|